Literature DB >> 8962241

Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.

J M Langrehr1, O Guckelberger, N Nüssler, A Radtke, H P Lemmens, S Jonas, R Lohmann, S Tullius, T Steinmüller, R Raakow, U Neumann, M Knoop, W O Bechstein, P Neuhaus.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8962241

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Options for induction immunosuppression in liver transplant recipients.

Authors:  Michael A J Moser
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.

Authors:  Luit Penninga; André Wettergren; Colin H Wilson; An-Wen Chan; Daniel A Steinbrüchel; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2014-06-05

3.  Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.

Authors:  Lawrence Mj Best; Jeffrey Leung; Suzanne C Freeman; Alex J Sutton; Nicola J Cooper; Elisabeth Jane Milne; Maxine Cowlin; Anna Payne; Dana Walshaw; Douglas Thorburn; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Norman R Williams; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.